Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 China SXT PharmaceuticalsSophiris BioUnum TherapeuticsAzurRx BioPharmaAEterna Zentaris
SymbolNASDAQ:SXTCNASDAQ:SPHSNASDAQ:UMRXNASDAQ:AZRXNASDAQ:AEZS
Price Information
Current Price$0.64$0.19$0.48$0.57$0.55
52 Week RangeN/ABuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationN/ABuyHoldBuyBuy
Consensus Price TargetN/A$4.40$6.50$5.67N/A
% Upside from Price TargetN/A2,185.71% upside1,268.42% upside898.53% upsideN/A
Trade Information
Market Cap$16.74 million$6.04 million$15.11 million$15.21 million$12.93 million
Beta-12.280.752.151.2
Average Volume1,706,196416,468303,456185,067313,842
Sales & Book Value
Annual Revenue$7.01 millionN/A$22.50 millionN/A$26.90 million
Price / Sales2.53N/A0.63N/A0.48
Cashflow$0.08 per shareN/AN/AN/A$0.23 per share
Price / Cash7.90N/AN/AN/A2.35
Book Value$0.49 per share$0.06 per share$2.01 per share$0.26 per share$0.12 per share
Price / Book1.31N/A0.24N/A4.58
Profitability
Net Income$1.54 million$-6,780,000.00$-34,530,000.00$-13,530,000.00$4.19 million
EPSN/A($0.52)($1.04)($0.88)N/A
Trailing P/E Ratio0.00N/AN/AN/AN/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-141.49%N/A-529.57%
Return on Equity (ROE)N/AN/A-81.16%-537.33%-1,428.66%
Return on Assets (ROA)N/A-110.71%-45.81%-202.02%-33.77%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.17%N/AN/A
Current RatioN/A1.79%1.96%0.64%2.34%
Quick RatioN/A1.79%1.96%0.64%2.23%
Ownership Information
Institutional Ownership Percentage7.94%9.30%32.52%5.87%5.44%
Insider Ownership PercentageN/A4.50%30.80%7.00%N/A
Miscellaneous
EmployeesN/A65612N/A
Shares Outstanding27.73 million35.55 million29.89 million26.80 million23.51 million
Next Earnings DateN/A4/1/2020 (Estimated)5/11/2020 (Estimated)4/6/2020 (Estimated)3/31/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel